Treating schizophrenia now and developing strategies for the next decade

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

This paper focuses on treatments for schizophrenia (SZ) - treatments we have now and those we hope to have in the future. The treatments we have are based on serendipity, but are effective nonetheless. Pharmacologic characteristics of the most-prescribed drugs are reviewed. It is apparent that a spectrum of effective drugs exist to support individualized therapy. With a view to future discovery, a strategy is proposed for rational antipsychotic drug development. A few concrete examples from the author's own laboratory illustrate an application of the proposal. These data would support the existence of a drug target in the anterior cingulate and/or hippocampal cortex. The studies suggest a focus on the limbic cortex for SZ pathophysiology. It would depend on future discovery to test whether this proposal will be productive. For sure, the rapid advance of basic neuroscience provides untold promise for the future.

Original languageEnglish (US)
Pages (from-to)987-991+1000
JournalCNS Spectrums
Volume6
Issue number12
StatePublished - 2001

Fingerprint

Schizophrenia
Pharmaceutical Preparations
Gyrus Cinguli
Neurosciences
Antipsychotic Agents
Therapeutics

ASJC Scopus subject areas

  • Neuropsychology and Physiological Psychology

Cite this

Treating schizophrenia now and developing strategies for the next decade. / Tamminga, Carol A.

In: CNS Spectrums, Vol. 6, No. 12, 2001, p. 987-991+1000.

Research output: Contribution to journalArticle

@article{19f1d0b471ba49acb190a37b77792276,
title = "Treating schizophrenia now and developing strategies for the next decade",
abstract = "This paper focuses on treatments for schizophrenia (SZ) - treatments we have now and those we hope to have in the future. The treatments we have are based on serendipity, but are effective nonetheless. Pharmacologic characteristics of the most-prescribed drugs are reviewed. It is apparent that a spectrum of effective drugs exist to support individualized therapy. With a view to future discovery, a strategy is proposed for rational antipsychotic drug development. A few concrete examples from the author's own laboratory illustrate an application of the proposal. These data would support the existence of a drug target in the anterior cingulate and/or hippocampal cortex. The studies suggest a focus on the limbic cortex for SZ pathophysiology. It would depend on future discovery to test whether this proposal will be productive. For sure, the rapid advance of basic neuroscience provides untold promise for the future.",
author = "Tamminga, {Carol A.}",
year = "2001",
language = "English (US)",
volume = "6",
pages = "987--991+1000",
journal = "CNS Spectrums",
issn = "1092-8529",
publisher = "MBL Communications",
number = "12",

}

TY - JOUR

T1 - Treating schizophrenia now and developing strategies for the next decade

AU - Tamminga, Carol A.

PY - 2001

Y1 - 2001

N2 - This paper focuses on treatments for schizophrenia (SZ) - treatments we have now and those we hope to have in the future. The treatments we have are based on serendipity, but are effective nonetheless. Pharmacologic characteristics of the most-prescribed drugs are reviewed. It is apparent that a spectrum of effective drugs exist to support individualized therapy. With a view to future discovery, a strategy is proposed for rational antipsychotic drug development. A few concrete examples from the author's own laboratory illustrate an application of the proposal. These data would support the existence of a drug target in the anterior cingulate and/or hippocampal cortex. The studies suggest a focus on the limbic cortex for SZ pathophysiology. It would depend on future discovery to test whether this proposal will be productive. For sure, the rapid advance of basic neuroscience provides untold promise for the future.

AB - This paper focuses on treatments for schizophrenia (SZ) - treatments we have now and those we hope to have in the future. The treatments we have are based on serendipity, but are effective nonetheless. Pharmacologic characteristics of the most-prescribed drugs are reviewed. It is apparent that a spectrum of effective drugs exist to support individualized therapy. With a view to future discovery, a strategy is proposed for rational antipsychotic drug development. A few concrete examples from the author's own laboratory illustrate an application of the proposal. These data would support the existence of a drug target in the anterior cingulate and/or hippocampal cortex. The studies suggest a focus on the limbic cortex for SZ pathophysiology. It would depend on future discovery to test whether this proposal will be productive. For sure, the rapid advance of basic neuroscience provides untold promise for the future.

UR - http://www.scopus.com/inward/record.url?scp=0035556259&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035556259&partnerID=8YFLogxK

M3 - Article

C2 - 15311191

AN - SCOPUS:0035556259

VL - 6

SP - 987-991+1000

JO - CNS Spectrums

JF - CNS Spectrums

SN - 1092-8529

IS - 12

ER -